Literature DB >> 839419

Aqueous chamber drug distribution volume measurement in rabbits.

J M Conrad, J R Robinson.   

Abstract

A method was developed for aqueous chamber drug distribution volume measurement in the albino rabbit, and the apparent volume of distribution was determined for inulin, pilocarpine alkaloid, and 1-hexanoic acid. The method consists of injecting a suitable concentration of drug, in an appropriate volume of fluid, into the anterior chamber of the eye and monitoring the decline in drug concentration as a function of time by periodic sampling of the aqueous humor. Graphical analysis of the resulting data yields both the apparent volume of distribution and the turnover rate constant of the aqueous humor. The technique does traumatize the eye, causing formation of plasmoid aqueous, which does not interfere with the apparent drug distribution volume measurement or the determination of aqueous humor turnover. Inulin was used to determine the physiological aqueous volume, 287 mul, in good agreement with literature values. The turnover rate constant was 0.016 min-1, also in good agreement with literature values. The apparent volume of distribution for pilocarpine alkaloid was 575 mul in albino eyes and 760 mul in pigmented irides; for 1-hexanoic acid in albino eyes, it was 760 mul. For pilocarpine alkaloid, literature citations on the fraction of dose absorbed have been based on an assumed apparent volume of distribution of 250-300 mul. Therefore, a factor of two error has been introduced when using albino eyes and a factor of almost three has been introduced when using pigmented eyes. The implication of the apparent volume of distribution for pilocarpine in its ocular disposition is discussed, as is the unexpected observation that pilocarpine alkaloid apparently inhibits formation of plasmoid aqueous and follows one-compartment kinetics during these studies. Is is shown that the one-compartment kinetics for pilocarpine are due to its biological activity in the aqueous chamber.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 839419     DOI: 10.1002/jps.2600660222

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  14 in total

1.  Role of P-glycoprotein in ocular clearance of rhodamine 123 in rabbits.

Authors:  T Kajikawa; H K Mishima; T Murakami; M Takano
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

2.  Biopharmaceutical evaluation of ibufenac, ibuprofen, and their hydroxyethoxy analogs in the rabbit eye.

Authors:  C S Rao; R D Schoenwald; C F Barfknecht; S L Laban
Journal:  J Pharmacokinet Biopharm       Date:  1992-08

3.  General Pharmacokinetic Model for Topically Administered Ocular Drug Dosage Forms.

Authors:  Feng Deng; Veli-Pekka Ranta; Heidi Kidron; Arto Urtti
Journal:  Pharm Res       Date:  2016-07-18       Impact factor: 4.200

Review 4.  Ocular drug delivery. Pharmacokinetic considerations.

Authors:  R D Schoenwald
Journal:  Clin Pharmacokinet       Date:  1990-04       Impact factor: 6.447

5.  The effect of azone on ocular levobunolol absorption: calculating the area under the curve and its standard error using tissue sampling compartments.

Authors:  D D Tang-Liu; P J Burke
Journal:  Pharm Res       Date:  1988-04       Impact factor: 4.200

6.  Impacts of nanomedicines in ocular pharmacotherapy.

Authors:  Ailar Nakhlband; Jaleh Barar
Journal:  Bioimpacts       Date:  2011-06-09

7.  Characterization of ocular pharmacokinetics of beta-blockers using a diffusion model after instillation.

Authors:  K Yamamura; H Sasaki; M Nakashima; M Ichikawa; T Mukai; K Nishida; J Nakamura
Journal:  Pharm Res       Date:  1999-10       Impact factor: 4.200

8.  Ocular pharmacokinetic models of clonidine-3H hydrochloride.

Authors:  C H Chiang; R D Schoenwald
Journal:  J Pharmacokinet Biopharm       Date:  1986-04

9.  Ocular and systemic bioavailability of ophthalmic flurbiprofen.

Authors:  D D Tang-Liu; S S Liu; R J Weinkam
Journal:  J Pharmacokinet Biopharm       Date:  1984-12

10.  Ocular pharmacokinetic/ pharmacodynamic modeling for bunazosin after instillation into rabbits.

Authors:  Koji Sakanaka; Kouichi Kawazu; Masahide Tomonari; Takashi Kitahara; Mikiro Nakashima; Shigeru Kawakami; Koyo Nishida; Junzo Nakamura; Hitoshi Sasaki
Journal:  Pharm Res       Date:  2004-05       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.